Showing results (291-300 of 323) with videos related to
Sort By:
Pageof 33
Cancer|October 18, 2024
Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09)Miso Kim, Yu Jung Kim, Koung Jin Suh, et al.Cancer Research and Treatment|November 2, 2019
Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)Kihwan Hwang, Tae Min Kim, Chul-Kee Park, et al.Thoracic Cancer|October 7, 2020
Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07Miso Kim, Bhumsuk Keam, Chan-Young Ock, et al.Journal of Cancer Research and Clinical Oncology|December 2, 2021
Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancersSang-A Kim, Hyejoo Park, Kui-Jin Kim, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2025
Preventing Infusion-Related Reactions With Intravenous Amivantamab-Results From SKIPPirr, a Phase 2 Study: A Brief ReportAlexander I Spira, Luis Paz-Ares, Ji-Youn Han, et al.BMC Psychiatry|June 2, 2025
Interaction effect of comorbid depression and proactive positivity coping strategy on the 1-year survival of patients with advanced cancer: a nationwide multicentre study in South KoreaJu Youn Jung, Je-Yeon Yun, Jung Hun Kang, et al.Clinical Lung Cancer|March 10, 2026
Subcutaneous Delivery of Amivantamab in Patients With Advanced Solid Malignancies: The Phase Ib PALOMA StudyAnna Minchom, Byoung Chul Cho, Natasha B Leighl, et al.Anticancer Research|April 28, 2026
Therapeutic Efficacy of PB101 and Chemotherapy Combination in Preclinical Gastric Cancer ModelsMinsung Park, Cheng Hyun Lee, Kui-Jin Kim, et al.Elife|December 8, 2022
Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumorsMinsu Kang, Hee Young Na, Soomin Ahn, et al.Journal of Neuro-Oncology|November 6, 2010
Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trialIl Han Kim, Chul-Kee Park, Dae Seog Heo, et al.Pageof 33